Unrevealing the vital role of ncRNAs in Gastric Cancer chemoresistance

被引:5
作者
Kazemi, Aida [1 ]
Goodarzi, Masomeh [2 ]
Daneshipour, Kosar [3 ]
Sarabadani, Hoda [4 ]
Shahpar, Zahra [5 ]
Hajiagha, Bahareh Salmanian [6 ]
Kheradjoo, Hadis [7 ]
Mohammadzadehsaliani, Saman [8 ]
机构
[1] Monash Univ, Dept Biomed Sci, Melbourne, Australia
[2] Zabol Univ Med Sci, Dept Biol, Zabol, Iran
[3] Islamic Azad Univ, Dept Biol Sci, North Tehran Branch, Tehran, Iran
[4] Bharati Vidyapeeth Univ, Rajiv Gandhi Inst Informat Technol & Biotechnol, Pune, India
[5] Istanbul Univ, Tech Dept, Istanbul, Turkiye
[6] Islamic Azad Univ, Fac Basic Sci, Dept Cellular & Mol Biol, East Tehran Branch, Tehran, Iran
[7] Buraimi Hosp, Lab Dept, Buraimi, Oman
[8] Buraimi Hosp, Ophthalmol Dept, Buraimi, Oman
关键词
Non-coding RNAs; Chemoresistance; Gastric cancer; CISPLATIN RESISTANCE; CELL-PROLIFERATION; CHEMOSENSITIVITY; HETEROGENEITY; INCREASES; PATHOLOGY;
D O I
10.1016/j.prp.2023.154761
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The high incidence of gastric cancer in many nations and poor overall survival rates has remained a serious global health concern. Chemoresistance in gastric cancer is a significant issue that hinders the efficacy of available treatment options. In gastric cancer, non-coding RNAs like microRNAs, long non-coding RNAs, and circular RNAs have become effective regulators of chemoresistance. These non-coding RNAs can influence several mechanisms, including drug efflux transporters, drug metabolism, and detoxification, cancer stem cells and the epithelial-mesenchymal transition, autophagy and apoptosis, and the tumor microenvironment. In this article review, we summarize the key roles non-coding RNAs play in the chemoresistance of gastric cancer and consider how they might be used in clinical settings as markers for diagnosis and prognosis, as well as potential targets and treatment plans. We also emphasize the need for additional study and collaborations in this area and highlight the difficulties and opportunities in non-coding RNA research for gastric cancer chemoresistance. This review offers crucial insights into the intricate relationship between non-coding RNAs and chemoresistance in gastric cancer, with implications for precision oncology and personalized medicine.
引用
收藏
页数:8
相关论文
共 74 条
[1]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]   Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance [J].
Ayers, Duncan ;
Vandesompele, Jo .
GENES, 2017, 8 (03)
[3]   fBlood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty [J].
Badowski, Cedric ;
He, Bing ;
Garmire, Lana X. .
NPJ PRECISION ONCOLOGY, 2022, 6 (01)
[4]   lncRNA HIT000218960 enhances resistance to 5-fluorouracil by promoting HMGA2 and activating the AKT/mTOR/P70S6K pathway in gastric cancer cells [J].
Bai, Li ;
Dong, Kunbo ;
Tong, Deyong ;
Shi, Xiuna ;
Wei, Sirong ;
Cai, Yongguo .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (02)
[5]   Non-coding RNAs and ferroptosis: potential implications for cancer therapy [J].
Balihodzic, Amar ;
Prinz, Felix ;
Dengler, Michael A. ;
Calin, George A. ;
Jost, Philipp J. ;
Pichler, Martin .
CELL DEATH AND DIFFERENTIATION, 2022, 29 (06) :1094-1106
[6]   Therapeutic advances of miRNAs: A preclinical and clinical update [J].
Chakraborty, Chiranjib ;
Sharma, Ashish Ranjan ;
Sharma, Garima ;
Lee, Sang-Soo .
JOURNAL OF ADVANCED RESEARCH, 2021, 28 :127-138
[7]   Targeting non-coding RNAs to overcome cancer therapy resistance [J].
Chen, BaoQing ;
Dragomir, Mihnea P. ;
Yang, Chen ;
Li, Qiaoqiao ;
Horst, David ;
Calin, George A. .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[8]   Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications [J].
Chen, Di ;
Ping, Shuai ;
Xu, Yushuang ;
Wang, Mengmeng ;
Jiang, Xin ;
Xiong, Lina ;
Zhang, Li ;
Yu, Honglu ;
Xiong, Zhifan .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[9]   Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics [J].
Chen, Mengyu ;
Lei, Ningjing ;
Tian, Wanjia ;
Li, Yong ;
Chang, Lei .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[10]   Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer [J].
Chen, Z. ;
Li, Y. ;
Tan, B. ;
Zhao, Q. ;
Fan, L. ;
Li, F. ;
Zhao, X. .
DRUGS OF TODAY, 2020, 56 (07) :469-482